Clinically Relevant Treatment of PDX Models Reveals Patterns of Neuroblastoma Chemoresistance

Investigators developed a clinically relevant in vivo treatment protocol mimicking the first-line five-chemotherapy treatment regimen of high-risk neuroblastoma (NB) and applied this protocol to mice with MYCN-amplified NB patient-derived xenografts.